Dr. Oh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4921 Parkview Pl
# Dv
Saint Louis, MO 63110Phone+1 314-362-7216Fax+1 314-362-8826
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Hematology, 2006 - 2010
- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2004 - 2006
- Northwestern University The Feinberg School of MedicineClass of 2004
Certifications & Licensure
- CA State Medical License 2005 - Present
- MO State Medical License 2010 - 2025
- American Board of Internal Medicine Hematology
Clinical Trials
- Integrated Whole-Genome Analysis of Hematologic Disorders Start of enrollment: 2009 Sep 01
- Investigation of Dysregulated Signaling in MPD Via Multiparameter Phospho-specific Flow Cytometry Start of enrollment: 2009 Sep 01
- Ruxolitinib for Chuvash Polycythemia
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsIn vivo ablation of NF-κB cascade effectors alleviates disease burden in myeloproliferative neoplasms.Angelo B A Laranjeira, Tim Kong, Steven C Snyder, Mary C Fulbright, Daniel A C Fisher
Blood. 2024-06-06 - 263 citationsThe Human Tumor Atlas Network: Charting Tumor Transitions Across Space and Time at Single-Cell ResolutionOrit Rozenblatt-Rosen, Aviv Regev, Philipp Oberdoerffer, Tal Nawy, Anna Hupalowska
Cell. 2020-04-16 - 582 citationsTP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic SyndromesJohn S. Welch, Allegra A. Petti, Christopher A. Miller, Catrina Fronick, Michelle O'Laughlin
The New England Journal of Medicine. 2016-11-23
Abstracts/Posters
- Single-Cell Pathway Enrichment and Regulatory Profiling of Multiple Myeloma across Disease StagesStephen T. Oh, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Altered Dynamics of Monocyte Subpopulations and Pro-Inflammatory Signaling Pathways in Polycythemia Vera Revealed By Mass CytometryStephen T. Oh, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Interrogating the Role of ASXL1 and JAK2 mutations in Myeloproliferative Neoplasms Utilizing Human Pluripotent Stem CellsStephen T. Oh, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: